Exploring the Potential of Chatbots in Critical Care Nephrology
Abstract
:1. Introduction
1.1. Definition and Overview of Chatbots
- (1)
- Natural language processing (NLP) forms the foundation of chatbot technology, a subfield of AI that empowers machines to comprehend and process human language [9,10,11]. NLP encompasses several essential elements, including the following: (1) Text preprocessing involves preparing text inputs from a chatbot for subsequent analysis. This stage entails removing unnecessary punctuation, converting the text to lowercase, and segmenting sentences into individual words (tokenization) [12]. (2) Language understanding focuses on extracting meaning from the preprocessed text. Methods like named entity recognition and part-of-speech tagging, and sentiment analysis are employed to identify entities, categorize words, and ascertain the sentiment underlying the user’s input [13]. (3) Intent recognition aims to discern the user’s intention or the purpose behind their input. Machine learning algorithms are trained to identify intent by analyzing user text patterns, enabling the chatbot to determine the appropriate response or action [2].
- (2)
- Machine learning plays a pivotal role in the development of chatbots, enabling them to learn from data and improve their performance [2,3,14]. In the context of chatbot development, several machine learning algorithms play pivotal roles: (1) Supervised learning: This approach involves training the chatbot using labeled datasets, where each input is paired with a predefined output. By learning from these examples, the algorithm can classify new inputs and generate appropriate responses. Supervised learning is particularly advantageous for tasks such as intent recognition and entity extraction [3]. (2) Unsupervised learning: Chatbots trained using this methodology rely on unlabeled datasets. The model is primarily built on self-learning derived from historical chat log data. This results in conversation interactions that are more diverse and natural compared to those generated through supervised learning. However, a potential drawback of unsupervised learning is the possibility of generating inaccurate results due to the absence of predefined outputs [15]. (3) Semi-supervised learning: This is a hybrid approach that combines elements of both supervised and unsupervised learning. It utilizes unlabeled data to cluster related information and subsequently labels these data to enhance the learning process [16]. (4) Reinforcement learning: This iterative methodology involves training the chatbot through a trial-and-error process [17]. The chatbot interacts with users, receives feedback on the quality of its responses, and adjusts its behavior based on this feedback. By maximizing the rewards received for desirable actions, reinforcement learning enables the chatbot to continuously refine and enhance its performance over time [3].
- (3)
- Dialogue management focuses on governing the flow of conversation between the chatbot and the user [13,18]. It encompasses three key components, including the following: (1) State tracking involves maintaining context throughout the conversation, including the user’s current goal, preferences, and previous interactions. By preserving this information, the chatbot can provide more personalized and contextually relevant responses [19,20]. (2) Policy learning determines how the chatbot selects responses based on the current state of the conversation. Policy learning algorithms are trained to optimize the chatbot’s decision-making process, considering user satisfaction, system constraints, and task completion [13]. (3) Response generation is the process by which the chatbot generates an appropriate action or response. This can range from simple template-based responses to more sophisticated approaches, such as natural language generation (NLG) or neural-network-based models that generate responses from scratch [9].
1.2. Introduction to the Potential Utilization of Chatbots in Critical Care Nephrology
2. The Future Imperative: Why We Need Chatbots in Critical Care Nephrology
2.1. Enhancing Efficiency and Workflow in Critical Care Settings
- Enhanced Communication and Retrieval of Information:
- Real-time Monitoring and Alerts:
- Clinical Decision Support:
- Patient Education and Empowerment:
- Round-the-Clock Availability and Support:
2.2. Improving Patient Outcomes and Safety
- Efficient Communication and Enhanced Safety:
- Continuous Monitoring and Follow-up Care:
3. Features of Chatbots in Critical Care Nephrology
3.1. Real-Time Assistance and Accessibility
3.2. Data Analysis and Decision Support
3.3. Personalized Patient Education
3.4. Access to Medical Literature and Guidelines
3.5. Language Processing and Multilingual Support
3.6. Integration with EHRs
3.7. Privacy and Security Measures
4. Challenges and Limitations of Chatbot Implementation
4.1. Addressing Privacy and Security Concerns
- Data Privacy and Confidentiality:
- Consent and Transparency:
- Authentication and Identity Verification:
- Secure Integration with Existing Systems:
- Ongoing Monitoring and Maintenance:
- Staff Training and Awareness:
4.2. Accuracy and Reliability Concerns
- Model drift
- Artificial hallucination
4.3. Ensuring Integration with Existing Healthcare Systems
- Achieving Compatibility and Interoperability:
- Integrating and Aggregating Data:
- Aligning Workflows and Processes:
5. Potential Applications of Chatbots in Critical Care Nephrology
5.1. Early Detection and Diagnosis of AKI
5.1.1. Real-Time Monitoring of Renal Function and Biomarkers
5.1.2. Identification of AKI Risk Factors and Predictive Modeling
5.1.3. Prompt Alert System for Early AKI Diagnosis
5.2. Support for AKI Management
5.2.1. Monitoring Kidney Function and Fluid Balance
5.2.2. Guiding Fluid and Electrolyte Management
5.2.3. Providing Education and Support to Patients and Caregivers
5.3. Support for CRRT
5.3.1. Monitoring CRRT Parameters and Adjustments
5.3.2. Guiding Prescription and Anticoagulation Management
5.3.3. Facilitating Troubleshooting and Providing Decision Support for CRRT-Related Issues
5.4. Support for Palliative Care in Critical Care Nephrology
5.4.1. Assisting with Symptom Management and Palliative Treatment Options
5.4.2. Facilitating Communication and End-of-Life Decision Making
5.4.3. Providing Emotional Support and Resources
6. Future Directions of Chatbot Integration in Critical Care Nephrology
7. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Montenegro, J.L.Z.; da Costa, C.A.; da Rosa Righi, R. Survey of conversational agents in health. Expert Syst. Appl. 2019, 129, 56–67. [Google Scholar] [CrossRef]
- Suta, P.; Lan, X.; Wu, B.; Mongkolnam, P.; Chan, J.H. An overview of machine learning in chatbots. Int. J. Mech. Eng. Robot. Res. 2020, 9, 502–510. [Google Scholar] [CrossRef]
- Nassehi, A.; Zhong, R.Y.; Li, X.; Epureanu, B.I. Chapter 11—Review of machine learning technologies and artificial intelligence in modern manufacturing systems. In Design and Operation of Production Networks for Mass Personalization in the Era of Cloud Technology; Mourtzis, D., Ed.; Elsevier: Amsterdam, The Netherlands, 2022; pp. 317–348. [Google Scholar]
- Weizenbaum, J. ELIZA—A computer program for the study of natural language communication between man and machine. Commun. ACM 1966, 9, 36–45. [Google Scholar] [CrossRef]
- Zemčík, M.T. A brief history of chatbots. DEStech Trans. Comput. Sci. Eng. 2019, 10. [Google Scholar] [CrossRef]
- Bassett, C. The computational therapeutic: Exploring Weizenbaum’s ELIZA as a history of the present. AI Soc. 2019, 34, 803–812. [Google Scholar] [CrossRef]
- Biswas, S.S. Role of Chat GPT in Public Health. Ann. Biomed. Eng. 2023, 51, 868–869. [Google Scholar] [CrossRef]
- Wilson, L.; Marasoiu, M. The Development and Use of Chatbots in Public Health: Scoping Review. JMIR Hum. Factors 2022, 9, e35882. [Google Scholar] [CrossRef]
- Khurana, D.; Koli, A.; Khatter, K.; Singh, S. Natural language processing: State of the art, current trends and challenges. Multimed. Tools Appl. 2023, 82, 3713–3744. [Google Scholar] [CrossRef]
- Kulkarni, C.S.; Bhavsar, A.U.; Pingale, S.R.; Kumbhar, S.S. BANK CHAT BOT–an intelligent assistant system using NLP and machine learning. Int. Res. J. Eng. Technol. 2017, 4, 2374–2377. [Google Scholar]
- Pavitha, N.; Bhatele, P.; Desai, S.; Pande, H. Design and Implementation of Multipurpose Chatbot. In Proceedings of the 2022 4th International Conference on Smart Systems and Inventive Technology (ICSSIT), Tirunelveli, India, 20–22 January 2022; pp. 1332–1337. [Google Scholar]
- A Complete Guide to Natural Language Processing. 2023. Available online: https://www.deeplearning.ai/resources/natural-language-processing/ (accessed on 7 June 2023).
- Adamopoulou, E.; Moussiades, L. An Overview of Chatbot Technology. In Artificial Intelligence Applications and Innovations 2020; Springer: Cham, Switzerland, 2020; Volume 584, pp. 373–383. [Google Scholar] [CrossRef]
- Janiesch, C.; Zschech, P.; Heinrich, K. Machine learning and deep learning. Electron. Mark. 2021, 31, 685–695. [Google Scholar] [CrossRef]
- Tebenkov, E.; Prokhorov, I. Machine learning algorithms for teaching AI chat bots. Procedia Comput. Sci. 2021, 190, 735–744. [Google Scholar] [CrossRef]
- Tamizharasi, B.; Jenila Livingston, L.M.; Rajkumar, S. Building a Medical Chatbot using Support Vector Machine Learning Algorithm. J. Phys. Conf. Ser. 2020, 1716, 012059. [Google Scholar] [CrossRef]
- Jadhav, H.M.; Mulani, A.; Jadhav, M.M. Design and Development of Chatbot Based on Reinforcement Learning. In Machine Learning Algorithms for Signal and Image Processing; John Wiley & Sons: Hoboken, NJ, USA, 2022; pp. 219–229. [Google Scholar]
- Vázquez, A.; López Zorrilla, A.; Olaso, J.M.; Torres, M.I. Dialogue Management and Language Generation for a Robust Conversational Virtual Coach: Validation and User Study. Sensors 2023, 23, 1423. [Google Scholar] [CrossRef] [PubMed]
- Gao, J.; Galley, M.; Li, L. Neural approaches to conversational AI. In Proceedings of the 41st International ACM SIGIR Conference on Research & Development in Information Retrieval, Ann Arbor, MI, USA, 8–12 July 2018; pp. 1371–1374. [Google Scholar]
- Yang, M.; Tu, W.; Qu, Q.; Zhao, Z.; Chen, X.; Zhu, J. Personalized response generation by dual-learning based domain adaptation. Neural Netw. 2018, 103, 72–82. [Google Scholar] [CrossRef] [PubMed]
- Doshi, J. Chatbot User Interface for Customer Relationship Management using NLP models. In Proceedings of the 2021 International Conference on Artificial Intelligence and Machine Vision (AIMV), Gandhinagar, India, 24–26 September 2021; pp. 1–4. [Google Scholar]
- Loftus, T.J.; Shickel, B.; Ozrazgat-Baslanti, T.; Ren, Y.; Glicksberg, B.S.; Cao, J.; Singh, K.; Chan, L.; Nadkarni, G.N.; Bihorac, A. Artificial intelligence-enabled decision support in nephrology. Nat. Rev. Nephrol. 2022, 18, 452–465. [Google Scholar] [CrossRef]
- Sidaoui, K.; Jaakkola, M.; Burton, J. AI feel you: Customer experience assessment via chatbot interviews. J. Serv. Manag. 2020, 31, 745–766. [Google Scholar] [CrossRef]
- Okonkwo, C.W.; Ade-Ibijola, A. Chatbots applications in education: A systematic review. Comput. Educ. Artif. Intell. 2021, 2, 100033. [Google Scholar] [CrossRef]
- Rajpurkar, P.; Chen, E.; Banerjee, O.; Topol, E.J. AI in health and medicine. Nat. Med. 2022, 28, 31–38. [Google Scholar] [CrossRef]
- Haug, C.J.; Drazen, J.M. Artificial Intelligence and Machine Learning in Clinical Medicine, 2023. N. Engl. J. Med. 2023, 388, 1201–1208. [Google Scholar] [CrossRef]
- Milne-Ives, M.; de Cock, C.; Lim, E.; Shehadeh, M.H.; de Pennington, N.; Mole, G.; Normando, E.; Meinert, E. The Effectiveness of Artificial Intelligence Conversational Agents in Health Care: Systematic Review. J. Med. Internet Res. 2020, 22, e20346. [Google Scholar] [CrossRef]
- Thongprayoon, C.; Kaewput, W.; Kovvuru, K.; Hansrivijit, P.; Kanduri, S.R.; Bathini, T.; Chewcharat, A.; Leeaphorn, N.; Gonzalez-Suarez, M.L.; Cheungpasitporn, W. Promises of Big Data and Artificial Intelligence in Nephrology and Transplantation. J. Clin. Med. 2020, 9, 1107. [Google Scholar] [CrossRef] [PubMed]
- Joshi, G.; Jain, A.; Adhikari, S.; Garg, H.; Bhandari, M. FDA approved Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices: An updated 2022 landscape. medRxiv 2023. [Google Scholar] [CrossRef]
- Mo, S.; Bjelland, T.W.; Nilsen, T.I.L.; Klepstad, P. Acute kidney injury in intensive care patients: Incidence, time course, and risk factors. Acta Anaesthesiol. Scand. 2022, 66, 961–968. [Google Scholar] [CrossRef]
- Melo, F.d.A.F.; Macedo, E.; Fonseca Bezerra, A.C.; Melo, W.A.L.d.; Mehta, R.L.; Burdmann, E.d.A.; Zanetta, D.M.T. A systematic review and meta-analysis of acute kidney injury in the intensive care units of developed and developing countries. PLoS ONE 2020, 15, e0226325. [Google Scholar] [CrossRef] [PubMed]
- Hoste, E.A.; Bagshaw, S.M.; Bellomo, R.; Cely, C.M.; Colman, R.; Cruz, D.N.; Edipidis, K.; Forni, L.G.; Gomersall, C.D.; Govil, D. Epidemiology of acute kidney injury in critically ill patients: The multinational AKI-EPI study. Intensive Care Med. 2015, 41, 1411–1423. [Google Scholar] [CrossRef] [PubMed]
- Davenport, T.; Kalakota, R. The potential for artificial intelligence in healthcare. Future Healthc. J. 2019, 6, 94–98. [Google Scholar] [CrossRef]
- Caldarini, G.; Jaf, S.; McGarry, K. A Literature Survey of Recent Advances in Chatbots. Information 2022, 13, 41. [Google Scholar] [CrossRef]
- Li, Y.; Liang, S.; Zhu, B.; Liu, X.; Li, J.; Chen, D.; Qin, J.; Bressington, D. Feasibility and effectiveness of artificial intelligence-driven conversational agents in healthcare interventions: A systematic review of randomized controlled trials. Int. J. Nurs. Stud. 2023, 143, 104494. [Google Scholar] [CrossRef]
- Gabarron, E.; Larbi, D.; Denecke, K.; Årsand, E. What Do We Know About the Use of Chatbots for Public Health? Stud. Health Technol. Inf. 2020, 270, 796–800. [Google Scholar] [CrossRef]
- Komorowski, M.; Del Pilar Arias López, M.; Chang, A.C. How could ChatGPT impact my practice as an intensivist? An overview of potential applications, risks and limitations. Intensive Care Med. 2023, 49, 844–847. [Google Scholar] [CrossRef]
- Lu, Y.; Wu, H.; Qi, S.; Cheng, K. Artificial Intelligence in Intensive Care Medicine: Toward a ChatGPT/GPT-4 Way? Ann. Biomed. Eng. 2023, 51, 1898–1903. [Google Scholar] [CrossRef] [PubMed]
- Alhasan, K.; Al-Tawfiq, J.; Aljamaan, F.; Jamal, A.; Al-Eyadhy, A.; Temsah, M.H. Mitigating the Burden of Severe Pediatric Respiratory Viruses in the Post-COVID-19 Era: ChatGPT Insights and Recommendations. Cureus 2023, 15, e36263. [Google Scholar] [CrossRef] [PubMed]
- Rehmat, M.A.; Hassan, M.A.; Khalid, M.H.; Dilawar, M. Next level of hospitalisation through smart ICU. Intell. Syst. Appl. 2022, 14, 200080. [Google Scholar] [CrossRef]
- Celi, L.A.; Hinske Christian, L.; Alterovitz, G.; Szolovits, P. An artificial intelligence tool to predict fluid requirement in the intensive care unit: A proof-of-concept study. Crit. Care 2008, 12, R151. [Google Scholar] [CrossRef] [PubMed]
- da Silva, R.; Baptista, A.; Serra, R.L.; Magalhães, D.S.F. Mobile application for the evaluation and planning of nursing workload in the intensive care unit. Int. J. Med. Inform. 2020, 137, 104120. [Google Scholar] [CrossRef]
- Thongprayoon, C.; Pattharanitima, P.; Kattah, A.G.; Mao, M.A.; Keddis, M.T.; Dillon, J.J.; Kaewput, W.; Tangpanithandee, S.; Krisanapan, P.; Qureshi, F.; et al. Explainable Preoperative Automated Machine Learning Prediction Model for Cardiac Surgery-Associated Acute Kidney Injury. J. Clin. Med. 2022, 11, 6264. [Google Scholar] [CrossRef]
- Chen, H.; Ma, Y.; Hong, N.; Wang, H.; Su, L.; Liu, C.; He, J.; Jiang, H.; Long, Y.; Zhu, W. Early warning of citric acid overdose and timely adjustment of regional citrate anticoagulation based on machine learning methods. BMC Med. Inform. Decis. Mak. 2021, 21, 1–11. [Google Scholar] [CrossRef]
- Avati, A.; Jung, K.; Harman, S.; Downing, L.; Ng, A.; Shah, N.H. Improving palliative care with deep learning. BMC Med. Inform. Decis. Mak. 2018, 18, 122. [Google Scholar] [CrossRef]
- Pou, P.A.; Gonzalez, I.A.; García, A.I.; Garcia-Fernandez, N. Improvement of drug prescribing in acute kidney injury with a nephrotoxic drug alert system. Eur. J. Hosp. Pharm. 2019, 26, 33–38. [Google Scholar]
- Chiofolo, C.; Chbat, N.; Ghosh, E.; Eshelman, L.; Kashani, K. Automated continuous acute kidney injury prediction and surveillance: A random forest model. Mayo Clin. Proc. 2019, 94, 783–792. [Google Scholar]
- Schwager, E.; Ghosh, E.; Eshelman, L.; Pasupathy, K.S.; Barreto, E.F.; Kashani, K. Accurate and interpretable prediction of ICU-acquired AKI. J. Crit. Care 2023, 75, 154278. [Google Scholar] [CrossRef] [PubMed]
- Thongprayoon, C.; Kattah, A.G.; Mao, M.A.; Keddis, M.T.; Pattharanitima, P.; Vallabhajosyula, S.; Nissaisorakarn, V.; Erickson, S.B.; Dillon, J.J.; Garovic, V.D.; et al. Distinct phenotypes of hospitalized patients with hyperkalemia by machine learning consensus clustering and associated mortality risks. QJM 2022, 115, 442–449. [Google Scholar] [CrossRef] [PubMed]
- Thongprayoon, C.; Hansrivijit, P.; Bathini, T.; Vallabhajosyula, S.; Mekraksakit, P.; Kaewput, W.; Cheungpasitporn, W. Predicting Acute Kidney Injury after Cardiac Surgery by Machine Learning Approaches. J. Clin. Med. 2020, 9, 1767. [Google Scholar] [CrossRef] [PubMed]
- Xu, L.; Sanders, L.; Li, K.; Chow, J.C.L. Chatbot for Health Care and Oncology Applications Using Artificial Intelligence and Machine Learning: Systematic Review. JMIR Cancer 2021, 7, e27850. [Google Scholar] [CrossRef] [PubMed]
- Schario, M.E.; Bahner, C.A.; Widenhofer, T.V.; Rajaballey, J.I.; Thatcher, E.J. Chatbot-assisted care management. Prof. Case Manag. 2022, 27, 19–25. [Google Scholar] [CrossRef]
- Safi, Z.; Abd-Alrazaq, A.; Khalifa, M.; Househ, M. Technical Aspects of Developing Chatbots for Medical Applications: Scoping Review. J. Med. Internet Res. 2020, 22, e19127. [Google Scholar] [CrossRef]
- Lin, C.H.; Ho, T.F.; Chen, H.F.; Chang, H.Y.; Chien, J.H. Applying Healthcare Failure Mode and Effect Analysis and the Development of a Real-Time Mobile Application for Modified Early Warning Score Notification to Improve Patient Safety During Hemodialysis. J. Patient Saf. 2022, 18, 475–485. [Google Scholar] [CrossRef]
- Demner-Fushman, D.; Chapman, W.W.; McDonald, C.J. What can natural language processing do for clinical decision support? J. Biomed. Inform. 2009, 42, 760–772. [Google Scholar] [CrossRef]
- Cheungpasitporn, W.; Kashani, K. Electronic Data Systems and Acute Kidney Injury. Contrib. Nephrol. 2016, 187, 73–83. [Google Scholar] [CrossRef]
- Mistry, N.S.; Koyner, J.L. Artificial Intelligence in Acute Kidney Injury: From Static to Dynamic Models. Adv. Chronic. Kidney Dis. 2021, 28, 74–82. [Google Scholar] [CrossRef]
- Sutherland, S.M.; Chawla, L.S.; Kane-Gill, S.L.; Hsu, R.K.; Kramer, A.A.; Goldstein, S.L.; Kellum, J.A.; Ronco, C.; Bagshaw, S.M.; Group, A.C. Utilizing electronic health records to predict acute kidney injury risk and outcomes: Workgroup statements from the 15th ADQI Consensus Conference. Can. J. Kidney Health Dis. 2016, 3, 99. [Google Scholar] [CrossRef] [PubMed]
- Pattharanitima, P.; Thongprayoon, C.; Kaewput, W.; Qureshi, F.; Qureshi, F.; Petnak, T.; Srivali, N.; Gembillo, G.; O’Corragain, O.A.; Chesdachai, S.; et al. Machine Learning Prediction Models for Mortality in Intensive Care Unit Patients with Lactic Acidosis. J. Clin. Med. 2021, 10, 5021. [Google Scholar] [CrossRef] [PubMed]
- Lachance, P.; Villeneuve, P.-M.; Rewa, O.G.; Wilson, F.P.; Selby, N.M.; Featherstone, R.M.; Bagshaw, S.M. Association between e-alert implementation for detection of acute kidney injury and outcomes: A systematic review. Nephrol. Dial. Transplant. 2017, 32, 265–272. [Google Scholar] [CrossRef]
- Miao, J.; Thongprayoon, C.; Garcia Valencia, O.A.; Krisanapan, P.; Sheikh, M.S.; Davis, P.W.; Mekraksakit, P.; Suarez, M.G.; Craici, I.M.; Cheungpasitporn, W. Performance of ChatGPT on Nephrology Test Questions. Clin. J. Am. Soc. Nephrol. 2023. [Google Scholar] [CrossRef] [PubMed]
- Guo, A.; Foraker, R.; White, P.; Chivers, C.; Courtright, K.; Moore, N. Using electronic health records and claims data to identify high-risk patients likely to benefit from palliative care. Am. J. Manag. Care 2021, 27, e7–e15. [Google Scholar] [CrossRef]
- Krisanapan, P.; Tangpanithandee, S.; Thongprayoon, C.; Pattharanitima, P.; Cheungpasitporn, W. Revolutionizing Chronic Kidney Disease Management with Machine Learning and Artificial Intelligence. J. Clin. Med. 2023, 12, 3018. [Google Scholar] [CrossRef]
- Jacobs, M.; Ogboye, A.; Mobisson, N. Harnessing human-centred design approaches to build a chatbot for people living with hypertension. J. Hypertens. 2022, 40, e195–e196. [Google Scholar] [CrossRef]
- Kosa, S.D.; Monize, J.; D’Souza, M.; Joshi, A.; Philip, K.; Reza, S.; Samra, S.; Serrago, B.; Thabane, L.; Gafni, A. Nutritional mobile applications for CKD patients: Systematic review. Kidney Int. Rep. 2019, 4, 399–407. [Google Scholar]
- Campbell, J.; Porter, J. Dietary mobile apps and their effect on nutritional indicators in chronic renal disease: A systematic review. Nephrology 2015, 20, 744–751. [Google Scholar]
- Li, W.-Y.; Chiu, F.-C.; Zeng, J.-K.; Li, Y.-W.; Huang, S.-H.; Yeh, H.-C.; Cheng, B.-W.; Yang, F.-J. Mobile health app with social media to support self-management for patients with chronic kidney disease: Prospective randomized controlled study. J. Med. Internet Res. 2020, 22, e19452. [Google Scholar] [CrossRef]
- May, R.; Denecke, K. Extending patient education with CLAIRE: An interactive virtual reality and voice user interface application. In Proceedings of the Addressing Global Challenges and Quality Education: 15th European Conference on Technology Enhanced Learning, EC-TEL 2020, Heidelberg, Germany, 14–18 September 2020; Proceedings 15, 2020. pp. 482–486. [Google Scholar]
- Hua, X.; Li, C.; Pogue, J.M.; Sharma, V.S.; Karaiskos, I.; Kaye, K.S.; Tsuji, B.T.; Bergen, P.J.; Zhu, Y.; Song, J.; et al. ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development Study. JMIR Mhealth Uhealth 2020, 8, e20525. [Google Scholar] [CrossRef] [PubMed]
- Torabikhah, M.; Farsi, Z.; Sajadi, S.A. Comparing the effects of mHealth app use and face-to-face training on the clinical and laboratory parameters of dietary and fluid intake adherence in hemodialysis patients: A randomized clinical trial. BMC Nephrol. 2023, 24, 194. [Google Scholar] [CrossRef] [PubMed]
- Marks, M.; Haupt, C.E. AI Chatbots, Health Privacy, and Challenges to HIPAA Compliance. JAMA 2023, 330, 309–310. [Google Scholar] [CrossRef] [PubMed]
- Kashani, K.B. Automated acute kidney injury alerts. Kidney Int. 2018, 94, 484–490. [Google Scholar] [CrossRef] [PubMed]
- Lee, N.S.; Luong, T.; Rosin, R.; Asch, D.A.; Sevinc, C.; Balachandran, M.; Josephs, M.; Rusk, M.H.; McHenry, N.L.; Asch, E.L.; et al. Developing a Chatbot–Clinician Model for Hypertension Management. NEJM Catal. 2022, 3, CAT.22.0228. [Google Scholar] [CrossRef]
- Ali, O.; Abdelbaki, W.; Shrestha, A.; Elbasi, E.; Alryalat, M.A.A.; Dwivedi, Y.K. A systematic literature review of artificial intelligence in the healthcare sector: Benefits, challenges, methodologies, and functionalities. J. Innov. Knowl. 2023, 8, 100333. [Google Scholar] [CrossRef]
- Darcy, A.M.; Louie, A.K.; Roberts, L.W. Machine Learning and the Profession of Medicine. JAMA 2016, 315, 551–552. [Google Scholar] [CrossRef]
- Hueso, M.; Vellido, A.; Montero, N.; Barbieri, C.; Ramos, R.; Angoso, M.; Cruzado, J.M.; Jonsson, A. Artificial Intelligence for the Artificial Kidney: Pointers to the Future of a Personalized Hemodialysis Therapy. Kidney Dis. 2018, 4, 1–9. [Google Scholar] [CrossRef]
- Schwager, E.; Lanius, S.; Ghosh, E.; Eshelman, L.; Pasupathy, K.S.; Barreto, E.F.; Kashani, K. Including urinary output to define AKI enhances the performance of machine learning models to predict AKI at admission. J. Crit. Care 2021, 62, 283–288. [Google Scholar] [CrossRef]
- De Vlieger, G.; Kashani, K.; Meyfroidt, G. Artificial intelligence to guide management of acute kidney injury in the ICU: A narrative review. Curr. Opin. Crit. Care 2020, 26, 563–573. [Google Scholar] [CrossRef]
- Chaix, B.; Bibault, J.-E.; Pienkowski, A.; Delamon, G.; Guillemassé, A.; Nectoux, P.; Brouard, B. When chatbots meet patients: One-year prospective study of conversations between patients with breast cancer and a chatbot. JMIR Cancer 2019, 5, e12856. [Google Scholar] [CrossRef] [PubMed]
- Kadariya, D.; Venkataramanan, R.; Yip, H.Y.; Kalra, M.; Thirunarayanan, K.; Sheth, A. kBot: Knowledge-Enabled Personalized Chatbot for Asthma Self-Management. In Proceedings of the 2019 IEEE International Conference on Smart Computing (SMARTCOMP), Washington, DC, USA, 12–15 June 2019; pp. 138–143. [Google Scholar]
- Furtado, E.S.; Oliveira, F.; Pinheiro, V. Conversational Assistants and their Applications in Health and Nephrology. In Innovations in Nephrology: Breakthrough Technologies in Kidney Disease Care; Bezerra da Silva Junior, G., Nangaku, M., Eds.; Springer International Publishing: Cham, Switzerland, 2022; pp. 283–303. [Google Scholar]
- Tsai, W.-C.; Li, W.-Y.; Tsai, J.-Y.; Yang, J.-S. Improving Self-diet Management of Chronic Kidney Disease Patients Through Chatbots. In Proceedings of the Human Aspects of IT for the Aged Population, Technology in Everyday Living, Virtual Event, 26 June–1 July 2022; pp. 268–276. [Google Scholar]
- Sallam, M. ChatGPT Utility in Healthcare Education, Research, and Practice: Systematic Review on the Promising Perspectives and Valid Concerns. Healthcare 2023, 11, 887. [Google Scholar] [CrossRef] [PubMed]
- Miao, J.; Thongprayoon, C.; Cheungpasitporn, W. Assessing the Accuracy of ChatGPT on Core Questions in Glomerular Disease. Kidney Int. Rep. 2023, 8, 1657–1659. [Google Scholar] [CrossRef] [PubMed]
- Vaishya, R.; Misra, A.; Vaish, A. ChatGPT: Is this version good for healthcare and research? Diabetes Metab. Syndr. Clin. Res. Rev. 2023, 17, 102744. [Google Scholar] [CrossRef] [PubMed]
- Olujimi, P.A.; Ade-Ibijola, A. NLP techniques for automating responses to customer queries: A systematic review. Discov. Artif. Intell. 2023, 3, 20. [Google Scholar] [CrossRef]
- Badlani, S.; Aditya, T.; Dave, M.; Chaudhari, S. Multilingual Healthcare Chatbot Using Machine Learning. In Proceedings of the 2021 2nd International Conference for Emerging Technology (INCET), Belagavi, India, 21–23 May 2021; pp. 1–6. [Google Scholar]
- Lal, H.; Lal, P. NLP chatbot for Discharge Summaries. In Proceedings of the 2019 2nd International Conference on Intelligent Communication and Computational Techniques (ICCT), Jaipur, India, 28–29 September 2019; pp. 250–257. [Google Scholar]
- Ralston, K.; Chen, Y.; Isah, H.; Zulkernine, F. A Voice Interactive Multilingual Student Support System using IBM Watson. In Proceedings of the 2019 18th IEEE International Conference On Machine Learning And Applications (ICMLA), Boca Raton, FL, USA, 16–19 December 2019; pp. 1924–1929. [Google Scholar]
- Haupt, C.E.; Marks, M. AI-Generated Medical Advice—GPT and Beyond. JAMA 2023, 329, 1349–1350. [Google Scholar] [CrossRef]
- Federspiel, F.; Mitchell, R.; Asokan, A.; Umana, C.; McCoy, D. Threats by artificial intelligence to human health and human existence. BMJ Glob. Health 2023, 8, e010435. [Google Scholar] [CrossRef]
- Chalmers, J.; Muir, R. Patient privacy and confidentiality: The debate goes on; the issues are complex, but a consensus is emerging. BMJ 2003, 326, 725–726. [Google Scholar] [CrossRef]
- Hasal, M.; Nowaková, J.; Ahmed Saghair, K.; Abdulla, H.; Snášel, V.; Ogiela, L. Chatbots: Security, privacy, data protection, and social aspects. Concurr. Comput. Pract. Exp. 2021, 33, e6426. [Google Scholar] [CrossRef]
- Ellahham, S.; Ellahham, N.; Simsekler, M.C.E. Application of artificial intelligence in the health care safety context: Opportunities and challenges. Am. J. Med. Qual. 2020, 35, 341–348. [Google Scholar] [CrossRef]
- Panch, T.; Pearson-Stuttard, J.; Greaves, F.; Atun, R. Artificial intelligence: Opportunities and risks for public health. Lancet Digit. Health 2019, 1, e13–e14. [Google Scholar] [CrossRef] [PubMed]
- Lu, J.; Liu, A.; Dong, F.; Gu, F.; Gama, J.; Zhang, G. Learning under concept drift: A review. IEEE Trans. Knowl. Data Eng. 2018, 31, 2346–2363. [Google Scholar] [CrossRef]
- Schröder, T.; Schulz, M. Monitoring machine learning models: A categorization of challenges and methods. Data Sci. Manag. 2022, 5, 105–116. [Google Scholar] [CrossRef]
- Dziri, N.; Milton, S.; Yu, M.; Zaiane, O.; Reddy, S. On the origin of hallucinations in conversational models: Is it the datasets or the models? arXiv 2022, arXiv:2204.07931. [Google Scholar]
- Alkaissi, H.; McFarlane, S.I. Artificial hallucinations in ChatGPT: Implications in scientific writing. Cureus 2023, 15, e35179. [Google Scholar] [CrossRef] [PubMed]
- Suppadungsuk, S.; Thongprayoon, C.; Krisanapan, P.; Tangpanithandee, S.; Garcia Valencia, O.; Miao, J.; Mekrasakit, P.; Kashani, K.; Cheungpasitporn, W. Examining the Validity of ChatGPT in Identifying Relevant Nephrology Literature: Findings and Implications. J. Clin. Med. 2023, 12, 5550. [Google Scholar] [CrossRef]
- Bhattacharyya, M.; Miller, V.M.; Bhattacharyya, D.; Miller, L.E. High Rates of Fabricated and Inaccurate References in ChatGPT-Generated Medical Content. Cureus 2023, 15, e39238. [Google Scholar] [CrossRef]
- Sujan, M.; Furniss, D.; Grundy, K.; Grundy, H.; Nelson, D.; Elliott, M.; White, S.; Habli, I.; Reynolds, N. Human factors challenges for the safe use of artificial intelligence in patient care. BMJ Health Care Inf. 2019, 26, e100081. [Google Scholar] [CrossRef]
- Chavez, M.R.; Butler, T.S.; Rekawek, P.; Heo, H.; Kinzler, W.L. Chat Generative Pre-trained Transformer: Why we should embrace this technology. Am. J. Obstet. Gynecol. 2023, 228, 706–711. [Google Scholar] [CrossRef]
- Ostermann, M.; Zarbock, A.; Goldstein, S.; Kashani, K.; Macedo, E.; Murugan, R.; Bell, M.; Forni, L.; Guzzi, L.; Joannidis, M.; et al. Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference: A Consensus Statement. JAMA Netw. Open 2020, 3, e2019209. [Google Scholar] [CrossRef]
- Ghosh, E.; Eshelman, L.; Lanius, S.; Schwager, E.; Pasupathy, K.S.; Barreto, E.F.; Kashani, K. Estimation of Baseline Serum Creatinine with Machine Learning. Am. J. Nephrol. 2021, 52, 753–762. [Google Scholar] [CrossRef] [PubMed]
- Dong, J.; Feng, T.; Thapa-Chhetry, B.; Cho, B.G.; Shum, T.; Inwald, D.P.; Newth, C.J.L.; Vaidya, V.U. Machine learning model for early prediction of acute kidney injury (AKI) in pediatric critical care. Crit. Care 2021, 25, 288. [Google Scholar] [CrossRef]
- Song, X.; Liu, X.; Liu, F.; Wang, C. Comparison of machine learning and logistic regression models in predicting acute kidney injury: A systematic review and meta-analysis. Int. J. Med. Inform. 2021, 151, 104484. [Google Scholar] [CrossRef] [PubMed]
- Zhu, W.; Barreto, E.F.; Li, J.; Lee, H.K.; Kashani, K. Drug-drug interaction and acute kidney injury development: A correlation-based network analysis. PLoS ONE 2023, 18, e0279928. [Google Scholar] [CrossRef]
- Wang, Y.; Wei, Y.; Yang, H.; Li, J.; Zhou, Y.; Wu, Q. Utilizing imbalanced electronic health records to predict acute kidney injury by ensemble learning and time series model. BMC Med. Inform. Decis. Mak. 2020, 20, 238. [Google Scholar] [CrossRef]
- Ostermann, M.; Liu, K.; Kashani, K. Fluid Management in Acute Kidney Injury. Chest 2019, 156, 594–603. [Google Scholar] [CrossRef]
- Shawwa, K.; Kashani, K.B. Prevention and Management of the Critically Injured Kidney. Int. Anesthesiol. Clin. 2019, 57, 48–60. [Google Scholar] [CrossRef] [PubMed]
- Kotanko, P.; Zhang, H.; Wang, Y. Artificial Intelligence and Machine Learning in Dialysis: Ready for Prime Time? Clin. J. Am. Soc. Nephrol. 2023, 18, 803–805. [Google Scholar] [CrossRef]
- Pack, S.; Lee, J. Randomised controlled trial of a smartphone application-based dietary self-management program on haemodialysis patients. J. Clin. Nurs. 2021, 30, 840–848. [Google Scholar] [CrossRef]
- Barbieri, C.; Cattinelli, I.; Neri, L.; Mari, F.; Ramos, R.; Brancaccio, D.; Canaud, B.; Stuard, S. Development of an Artificial Intelligence Model to Guide the Management of Blood Pressure, Fluid Volume, and Dialysis Dose in End-Stage Kidney Disease Patients: Proof of Concept and First Clinical Assessment. Kidney Dis. 2019, 5, 28–33. [Google Scholar] [CrossRef]
- Torabi Khah, M.; Farsi, Z.; Sajadi, S.A. Comparing the effects of mHealth application based on micro-learning method and face-to-face training on treatment adherence and perception in haemodialysis patients: A randomised clinical trial. BMJ Open 2023, 13, e071982. [Google Scholar] [CrossRef] [PubMed]
- da Silva Junior, G.B.; de Oliveira, J.G.R.; de Araújo, E.M.R.; Albuquerque, A.; Mota, F.A.X.; de Freitas Filho, R.A.; de Vasconcelos Filho, J.E.; Rodrigues, M.A.F. Renal Health: Providing Information and Technological Tools to Empower Patients to Live Better with Kidney Disease. Stud. Health Technol. Inform. 2021, 281, 674–678. [Google Scholar] [CrossRef] [PubMed]
- Malkina, A.; Tuot, D.S. Role of telehealth in renal replacement therapy education. Semin. Dial. 2018, 31, 129–134. [Google Scholar] [CrossRef]
- Singh, K. Mobile Health in Dialysis: The Best Engagement Medium Is the One that’s with Patients. Clin. J. Am. Soc. Nephrol. 2021, 16, 12–13. [Google Scholar] [CrossRef] [PubMed]
- Hammouda, N.; Neyra, J.A. Can Artificial Intelligence Assist in Delivering Continuous Renal Replacement Therapy? Adv. Chronic Kidney Dis. 2022, 29, 439–449. [Google Scholar] [CrossRef]
- Liu, L.J.; Takeuchi, T.; Chen, J.; Neyra, J.A. Artificial Intelligence in Continuous Kidney Replacement Therapy. Clin. J. Am. Soc. Nephrol. 2023, 18, 671–674. [Google Scholar] [CrossRef]
- Zhang, L.; Baldwin, I.; Zhu, G.; Tanaka, A.; Bellomo, R. Automated electronic monitoring of circuit pressures during continuous renal replacement therapy: A technical report. Crit. Care Resusc. 2015, 17, 51–54. [Google Scholar] [CrossRef]
- Zhang, W.; Bai, M.; Zhang, L.; Yu, Y.; Li, Y.; Zhao, L.; Yue, Y.; Li, Y.; Zhang, M.; Fu, P. Development and external validation of a model for predicting sufficient filter lifespan in anticoagulation-free continuous renal replacement therapy patients. Blood Purif. 2022, 51, 668–678. [Google Scholar] [CrossRef]
- Chua, I.S.; Ritchie, C.S.; Bates, D.W. Enhancing serious illness communication using artificial intelligence. NPJ Digit. Med. 2022, 5, 14. [Google Scholar] [CrossRef]
- Linder, C. The Effects of a Healthcare Chatbots’ Language and Persona on User Trust, Satisfaction, and Chatbot Effectiveness. Master’s Thesis, Clemson University, Clemson, SC, USA, 2020. [Google Scholar]
- Bibault, J.E.; Chaix, B.; Guillemassé, A.; Cousin, S.; Escande, A.; Perrin, M.; Pienkowski, A.; Delamon, G.; Nectoux, P.; Brouard, B. A Chatbot Versus Physicians to Provide Information for Patients With Breast Cancer: Blind, Randomized Controlled Noninferiority Trial. J. Med. Internet Res. 2019, 21, e15787. [Google Scholar] [CrossRef]
- Cox, C.E.; Jones, D.M.; Reagan, W.; Key, M.D.; Chow, V.; McFarlin, J.; Casarett, D.; Creutzfeldt, C.J.; Docherty, S.L. Palliative Care Planner: A Pilot Study to Evaluate Acceptability and Usability of an Electronic Health Records System-integrated, Needs-targeted App Platform. Ann. Am. Thorac. Soc. 2018, 15, 59–68. [Google Scholar] [CrossRef] [PubMed]
- Vu, E.; Steinmann, N.; Schröder, C.; Förster, R.; Aebersold, D.M.; Eychmüller, S.; Cihoric, N.; Hertler, C.; Windisch, P.; Zwahlen, D.R. Applications of Machine Learning in Palliative Care: A Systematic Review. Cancers 2023, 15, 1596. [Google Scholar] [CrossRef]
- Murphree, D.H.; Wilson, P.M.; Asai, S.W.; Quest, D.J.; Lin, Y.; Mukherjee, P.; Chhugani, N.; Strand, J.J.; Demuth, G.; Mead, D.; et al. Improving the delivery of palliative care through predictive modeling and healthcare informatics. J. Am. Med. Inform. Assoc. 2021, 28, 1065–1073. [Google Scholar] [CrossRef] [PubMed]
- Radionova, N.; Becker, G.; Mayer-Steinacker, R.; Gencer, D.; Rieger, M.A.; Preiser, C. The views of physicians and nurses on the potentials of an electronic assessment system for recognizing the needs of patients in palliative care. BMC Palliat. Care 2020, 19, 45. [Google Scholar] [CrossRef] [PubMed]
- Zhang, H.; Li, Y.; McConnell, W. Predicting potential palliative care beneficiaries for health plans: A generalized machine learning pipeline. J. Biomed. Inform. 2021, 123, 103922. [Google Scholar] [CrossRef] [PubMed]
- Muscat, D.M.; Lambert, K.; Shepherd, H.; McCaffery, K.J.; Zwi, S.; Liu, N.; Sud, K.; Saunders, J.; O’Lone, E.; Kim, J.; et al. Supporting patients to be involved in decisions about their health and care: Development of a best practice health literacy App for Australian adults living with Chronic Kidney Disease. Health Promot. J. Austr. 2021, 32 (Suppl. 1), 115–127. [Google Scholar] [CrossRef]
- Patzer, R.E.; Basu, M.; Larsen, C.P.; Pastan, S.O.; Mohan, S.; Patzer, M.; Konomos, M.; McClellan, W.M.; Lea, J.; Howard, D.; et al. iChoose Kidney: A Clinical Decision Aid for Kidney Transplantation Versus Dialysis Treatment. Transplantation 2016, 100, 630–639. [Google Scholar] [CrossRef]
- De Panfilis, L.; Peruselli, C.; Tanzi, S.; Botrugno, C. AI-based clinical decision-making systems in palliative medicine: Ethical challenges. BMJ Support. Palliat. Care 2023, 13, 183–189. [Google Scholar] [CrossRef]
- Webb, J.J. Proof of Concept: Using ChatGPT to Teach Emergency Physicians How to Break Bad News. Cureus 2023, 15, e38755. [Google Scholar] [CrossRef]
- Ayers, J.W.; Poliak, A.; Dredze, M.; Leas, E.C.; Zhu, Z.; Kelley, J.B.; Faix, D.J.; Goodman, A.M.; Longhurst, C.A.; Hogarth, M.; et al. Comparing Physician and Artificial Intelligence Chatbot Responses to Patient Questions Posted to a Public Social Media Forum. JAMA Intern. Med. 2023, 183, 589–596. [Google Scholar] [CrossRef]
- Xygkou, A.; Siriaraya, P.; Covaci, A.; Prigerson, H.G.; Neimeyer, R.; Ang, C.S.; She, W.-J. The “Conversation” about Loss: Understanding How Chatbot Technology was Used in Supporting People in Grief. In Proceedings of the 2023 CHI Conference on Human Factors in Computing Systems, Hamburg, Germany, 23–29 April 2023; pp. 1–15. [Google Scholar]
- Lisetti, C.; Amini, R.; Yasavur, U.; Rishe, N. I can help you change! An empathic virtual agent delivers behavior change health interventions. ACM Trans. Manag. Inf. Syst. 2013, 4, 1–28. [Google Scholar] [CrossRef]
- Yang, J.H.; Shin, G. End-of-Life Care Mobile App for Intensive-Care Unit Nurses: A Quasi-Experimental Study. Int. J. Environ. Res. Public Health 2021, 18, 1253. [Google Scholar] [CrossRef] [PubMed]
- Drummond, D. Between competence and warmth: The remaining place of the physician in the era of artificial intelligence. NPJ Digit. Med. 2021, 4, 85. [Google Scholar] [CrossRef] [PubMed]
Challenges/Limitations | Suggestions and Implementation |
---|---|
Data privacy and confidentiality |
|
| |
| |
| |
Consent and transparency |
|
| |
| |
| |
Authentication and identity verification |
|
| |
| |
Secure integration with existing systems |
|
| |
| |
Ongoing monitoring and maintenance |
|
| |
| |
| |
Staff training and awareness |
|
| |
|
Case Scenario 1: Alarms and Technical Difficulties | |
---|---|
Healthcare Provider | “I have encountered an alarm on the CRRT machine and require assistance in addressing it”. |
Chatbot | “I can provide troubleshooting support for the alarm. Please follow these steps: |
| |
| |
| |
| |
Healthcare Provider | “The alarm message on the machine indicates ‘Low Blood Flow Rate.’” |
Chatbot | “To resolve the low blood flow rate alarm, please undertake the following actions: |
| |
| |
| |
| |
Case Scenario 2: Adjusting CRRT Prescription | |
Healthcare Provider | “The patient’s clinical condition has deteriorated, and I believe adjustments to the CRRT prescription are necessary”. |
Chatbot | “I can assist in modifying the CRRT prescription. Please provide the following information:
|
Healthcare Provider | “The patient has experienced a significant increase in fluid overload”. |
Chatbot | “Considering the heightened fluid overload, you may contemplate the following modifications to the CRRT prescription:
|
Case Scenario 3: Determining Optimal Duration of CRRT | |
Healthcare Provider | “The patient has been undergoing CRRT for several days, and I’m uncertain about the appropriate timing to discontinue the therapy”. |
Chatbot | “I can offer guidance regarding the optimal duration of CRRT. Please provide the following information:
|
Healthcare Provider | “The patient’s fluid balance has improved, and kidney function is gradually recovering”. |
Chatbot | “Considering the enhanced fluid balance and progressive kidney function recovery, the following factors may assist in determining the optimal duration of CRRT:
|
Scenario | Chatbot Intervention |
---|---|
Patient with severe kidney injury and no dialysis option | The chatbot initiates a compassionate conversation, acknowledging the patient’s unique circumstances. It imparts information on alternative treatment modalities such as conservative management and palliative care. Moreover, the chatbot offers accessible resources, elucidating the advantages of symptom management, comfort measures, and supportive care. It underscores the significance of transparent communication with the healthcare team to address the patient’s needs and preferences adequately. |
Patient on dialysis with poor prognosis and considering withdrawal | The chatbot provides a supportive and empathetic response, acknowledging the patient’s challenging decision. It imparts information on the potential benefits associated with withdrawing dialysis, focusing on comfort measures, and enhancing the patient’s overall quality of life. The chatbot emphasizes the importance of discussing this with the healthcare team, including nephrologists and palliative care specialists. It offers resources that provide comprehensive information about advance care planning, end-of-life discussions, and emotional support services. Additionally, the chatbot encourages the patient to involve their loved ones in the decision-making process, while reassuring them of the availability of healthcare professionals to address their concerns. |
Family member seeking guidance on withdrawing dialysis | The chatbot engages in a compassionate conversation with the family member, acknowledging their concerns and emotions. It provides trustworthy information on various coping mechanisms, grief counseling services, and support groups tailored to individuals with kidney-related illnesses. The chatbot emphasizes the availability of healthcare professionals and encourages patients or family members to seek additional support as required. It offers links to resources to help them effectively navigate the emotional challenges associated with severe kidney injury and difficult treatment decisions. |
Patient or family member seeking emotional support and resources | The chatbot offers a safe and empathetic platform for patients or family members to express their emotions and address their concerns. It provides trustworthy information on various coping mechanisms, grief counseling services, and support groups specifically tailored to individuals dealing with kidney-related illnesses. The chatbot emphasizes the availability of healthcare professionals and encourages patients or family members to seek additional support as required. It offers links to resources that can potentially help them effectively navigate the emotional challenges associated with severe kidney injury and difficult treatment decisions. |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Suppadungsuk, S.; Thongprayoon, C.; Miao, J.; Krisanapan, P.; Qureshi, F.; Kashani, K.; Cheungpasitporn, W. Exploring the Potential of Chatbots in Critical Care Nephrology. Medicines 2023, 10, 58. https://doi.org/10.3390/medicines10100058
Suppadungsuk S, Thongprayoon C, Miao J, Krisanapan P, Qureshi F, Kashani K, Cheungpasitporn W. Exploring the Potential of Chatbots in Critical Care Nephrology. Medicines. 2023; 10(10):58. https://doi.org/10.3390/medicines10100058
Chicago/Turabian StyleSuppadungsuk, Supawadee, Charat Thongprayoon, Jing Miao, Pajaree Krisanapan, Fawad Qureshi, Kianoush Kashani, and Wisit Cheungpasitporn. 2023. "Exploring the Potential of Chatbots in Critical Care Nephrology" Medicines 10, no. 10: 58. https://doi.org/10.3390/medicines10100058